A. Heimberger, L. Kong, Mohamed K. Abou-Ghazal, Chantal Reina-Ortiz, David S. Yang, Jun Wei, W. Qiao, R. Schmittling, G. Archer, J. Sampson, N. Hiraoka, W. Priebe, G. Fuller, R. Sawaya
{"title":"tregs在人类胶质瘤患者中的作用及一种新型STAT-3抑制剂对其的抑制作用。","authors":"A. Heimberger, L. Kong, Mohamed K. Abou-Ghazal, Chantal Reina-Ortiz, David S. Yang, Jun Wei, W. Qiao, R. Schmittling, G. Archer, J. Sampson, N. Hiraoka, W. Priebe, G. Fuller, R. Sawaya","doi":"10.1227/01.NEU.0000333524.54656.42","DOIUrl":null,"url":null,"abstract":"Several recent clinical trials for high-grade gliomas have demonstrated promising results. Nonetheless, despite improvement in survival, these patients ultimately die of tumor progression. Malignant glioma patients are profoundly immunosuppressed, and a fundamental understanding of which types of glioma have immune resistance mediated by Tregs is required for developing and initiating specific immunotherapeutic approaches that may target these cells.","PeriodicalId":10381,"journal":{"name":"Clinical neurosurgery","volume":"10 1","pages":"98-106"},"PeriodicalIF":0.0000,"publicationDate":"2008-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"21","resultStr":"{\"title\":\"The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.\",\"authors\":\"A. Heimberger, L. Kong, Mohamed K. Abou-Ghazal, Chantal Reina-Ortiz, David S. Yang, Jun Wei, W. Qiao, R. Schmittling, G. Archer, J. Sampson, N. Hiraoka, W. Priebe, G. Fuller, R. Sawaya\",\"doi\":\"10.1227/01.NEU.0000333524.54656.42\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Several recent clinical trials for high-grade gliomas have demonstrated promising results. Nonetheless, despite improvement in survival, these patients ultimately die of tumor progression. Malignant glioma patients are profoundly immunosuppressed, and a fundamental understanding of which types of glioma have immune resistance mediated by Tregs is required for developing and initiating specific immunotherapeutic approaches that may target these cells.\",\"PeriodicalId\":10381,\"journal\":{\"name\":\"Clinical neurosurgery\",\"volume\":\"10 1\",\"pages\":\"98-106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"21\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical neurosurgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1227/01.NEU.0000333524.54656.42\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1227/01.NEU.0000333524.54656.42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Several recent clinical trials for high-grade gliomas have demonstrated promising results. Nonetheless, despite improvement in survival, these patients ultimately die of tumor progression. Malignant glioma patients are profoundly immunosuppressed, and a fundamental understanding of which types of glioma have immune resistance mediated by Tregs is required for developing and initiating specific immunotherapeutic approaches that may target these cells.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
